AzTrials
AzTrials

DyssomniasNCT02612987

iCBT for Adolescents With Co-morbid Insomnia

A study testing Internet-based Cognitive Behaviour Therapy (iCBT) in people with Dyssomnias, run by Uppsala University Hospital at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Insomnia is a commonly reported comorbidity for adolescents with psychiatric conditions. It is well-known that insomnia can exacerbate the concurrent psychiatric symptom load. Treatment of insomnia has been extensively examined in adults, but studies with adolescents are sparse. Read more about this study

Who is it for?
Ages 13 to 18 years
Conditions the study is for
Dyssomnias
What is being tested?
Internet-based Cognitive Behaviour Therapy (iCBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteSweden
Study dates
Oct 2015to Oct 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • To fulfill the diagnostic criteria for insomnia
  • To have access to a computer with Internet connection
  • No previous or ongoing CBT for insomnia
  • No psychotropic medication or being on a stable dosage for at least six weeks before enrollment

Who cannot join

  • Ongoing manic or psychotic episode
  • Being at high risk of triggering manic or psychotic episode
  • Ongoing sleep apnea

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Uppsala University Hospital

    Uppsala, Uppsala County, 751 85

Other trials in Sweden

About this study

Official title: Internet-delivered Cognitive Behaviour Therapy for Adolescents With Co-morbid Insomnia Attending Children and Youth Psychiatry: An Open Trial

Insomnia is a commonly reported comorbidity for adolescents with psychiatric conditions. It is well-known that insomnia can exacerbate the concurrent psychiatric symptom load. Treatment of insomnia has been extensively examined in adults, but studies with adolescents are sparse. The purpose of this pilot study is to assess the feasibility and efficacy of internet-based cognitive behavioral therapy for insomnia (iCBT) in outpatients of Children and Youth Psychiatry. Twenty-one adolescents will be recruited and receive 7 weeks of iCBT. Outcome will be measured at pre treatment, at post treatment and at a three months follow-up. Weekly assessments will also be made during treatment on primary outcome and a presumed process variable constructed for the purpose of this trial.

Conditions
Dyssomnias
Being tested
Internet-based Cognitive Behaviour Therapy (iCBT)
Keywords
CBT, Internet based
Medical subject headings
Dyssomnias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-based Cognitive Behaviour Therapy (iCBT)Behavioural

Study groups in NCT02612987
Study groupRoleWhat they receive
iCBTExperimentalNot described
Receives: Behavioral: Internet-based Cognitive Behaviour Therapy (iCBT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insomnia Severity Index (ISI; Morin, 1993)

    Given that this is an intervention study we are assessing changes in outcome over time.

    Measured: Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up

Secondary outcomes (3)
  1. The Core Consensus Sleep Diary (Core CSD; Carney et al., 2012)

    Given that this is an intervention study we are assessing changes in outcome over time.

    Measured: Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up

  2. Symptoms Checklist (SCL-90; Derogatis et al., 1994)

    Given that this is an intervention study we are assessing changes in outcome over time.

    Measured: Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up

  3. Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S; Svanborg & Åsberg, 1994)

    Given that this is an intervention study we are assessing changes in outcome over time.

    Measured: Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionOct 2017
  4. Study completionOct 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02612987
Sponsor's protocol ID
2015/326
Status last verified
Mar 2018
First submitted
15 Nov 2015
Last updated
5 Mar 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Internet-based Cognitive Behaviour Therapy (iCBT) in people with Dyssomnias, run by Uppsala University Hospital at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insomnia Severity Index (ISI; Morin, 1993) (time frame: Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in